Recombinant human interleukin-3 (IL-3) multiple mutation polypep

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530351, 424 852, 536 235, 930141, C07K 1454, C12N 1524, A61K 3820

Patent

active

058174869

ABSTRACT:
The present invention relates to recombinant human interleukin-3 (hIL-3) variant or mutant proteins (muteins). These hIL-3 muteins contain amino acid substitutions and may also have amino acid deletions at both the N- and C-termini. The invention also relates to pharmaceutical compositions containing the hIL-3 muteins and methods for using them. Additionally, the present invention relates to recombinant expression vectors comprising nucleotide sequences encoding the hIL-3 muteins, related microbial expression systems, and processes for making the hIL-3 muteins using the microbial expression systems. Included in the present invention are deletion mutants of hIL-3 in which from 1 to 14 amino acids have been deleted from the N-terminus, and from 1 to 15 amino acids (a.a.119 to 133) have been deleted from the C-terminus, and which also contain amino acid substitutions in the polypeptide. These hIL-3 multiple mutation polypeptides may have biological activities similar to or better than hIL-3 and, in some cases, may also have an improved side effect profile.

REFERENCES:
patent: 4877729 (1989-10-01), Clark et al.
patent: 4959455 (1990-09-01), Clark et al.
patent: 5032395 (1991-07-01), Clark et al.
patent: 5166322 (1992-11-01), Shaw et al.
patent: 5591427 (1997-01-01), Vadas et al.
patent: 5604116 (1997-02-01), Bauer et al.
Yang et al., in Cell 47:3 (1986).
Dorsers et al., Gene 55:115 (1987).
Phillips et al., Gene, 84, 501 (1989).
Clark-Lewis et al., Science 231:134 (1986).
Clark-Lewis et al., Proc. Nat. Acad. Sci. USA 85:7897 (1988).
Lokker et al., J. Biol Chem., 266(16):10624 (1991).
Clark-Lewis et al, Immune Regulation by Characterized Polypeptides, Alan R. Liss, Inc. (1987) pp. 323-334.
Ihle et al, J. Immunol. 126:2184 (1981).
Fung et al., Nature, 307, 233 (1984).
Yokota et al., Proc. Nat. Acad. Sci. USA 81:1070 (1984).
Dorssers et al., J. Biol. Chem 266(31):21310 (1991).
Koshansky et al, J. Clin. Invest, 90:1879 (1992).
Lopez et al., Proc. Natl. Acad. Sci. USA 89:11842-11846 (1992).
Lokker et al., The Embo Jour. 10:2125-2131 (1991).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Recombinant human interleukin-3 (IL-3) multiple mutation polypep does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant human interleukin-3 (IL-3) multiple mutation polypep, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant human interleukin-3 (IL-3) multiple mutation polypep will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-75971

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.